35 related articles for article (PubMed ID: 24623151)
1. 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma.
Sperti C; Pasquali C; Chierichetti F; Ferronato A; Decet G; Pedrazzoli S
J Gastrointest Surg; 2003 Dec; 7(8):953-9; discussion 959-60. PubMed ID: 14675704
[TBL] [Abstract][Full Text] [Related]
2. Correlation between 18-FDG standardized uptake value and tumor grade in patients with resectable non-small cell lung cancer.
Kużdżał B; Moszczyński K; Żanowska K; Hauer J; Popovchenko S; Bryndza M; Warmus J; Trybalski Ł; Rudnicka L; Kocoń P
Transl Cancer Res; 2023 Dec; 12(12):3530-3537. PubMed ID: 38192987
[TBL] [Abstract][Full Text] [Related]
3. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.
Schmidt-Hansen M; Baldwin DR; Hasler E; Zamora J; Abraira V; Roqué I Figuls M
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009519. PubMed ID: 25393718
[TBL] [Abstract][Full Text] [Related]
4. A unique case of a typical pancreatic ductal adenocarcinoma that initially presented with a cystic component but underwent morphological changes.
Nabeshima Y; Takemura N; Mihara F; Yoshizaki Y; Nakamura M; Kokudo T; Inagaki F; Kokudo N
Clin J Gastroenterol; 2024 Mar; ():. PubMed ID: 38519755
[TBL] [Abstract][Full Text] [Related]
5. Multiparameter diagnostic model based on
Wang G; Du L; Lu X; Chen S; Bi X; Zhang M; Luan X; Xu X; Zhang Z; Xu B; Yang J
Quant Imaging Med Surg; 2023 Sep; 13(9):5653-5663. PubMed ID: 37711769
[TBL] [Abstract][Full Text] [Related]
6. Advancements of molecular imaging and radiomics in pancreatic carcinoma.
Pang XX; Xie L; Yao WJ; Liu XX; Pan B; Chen N
World J Radiol; 2023 Jan; 15(1):10-19. PubMed ID: 36721672
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of
Xian WJ; Feng YL; Wang Y; Yang M; Lu SN
Br J Radiol; 2022 Jan; 95(1129):20210279. PubMed ID: 34813375
[TBL] [Abstract][Full Text] [Related]
8. Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Kang JS; Mok L; Heo JS; Han IW; Shin SH; Yoon YS; Han HS; Hwang DW; Lee JH; Lee WJ; Park SJ; Park JS; Kim Y; Lee H; Yu YD; Yang JD; Lee SE; Park IY; Jeong CY; Roh Y; Kim SR; Moon JI; Lee SK; Kim HJ; Lee S; Kim H; Kwon W; Lim CS; Jang JY; Park T
Gut Liver; 2021 Nov; 15(6):912-921. PubMed ID: 33941710
[TBL] [Abstract][Full Text] [Related]
9.
Gao XC; Wei CH; Zhang RG; Cai Q; He Y; Tong F; Dong JH; Wu G; Dong XR
Oncol Lett; 2020 Oct; 20(4):61. PubMed ID: 32863894
[TBL] [Abstract][Full Text] [Related]
10. Value of Pretreatment
Barnes CA; Aldakkak M; Clarke CN; Christians KK; Bucklan D; Holt M; Tolat P; Ritch PS; George B; Hall WA; Erickson BA; Evans DB; Tsai S
Front Oncol; 2020; 10():500. PubMed ID: 32363161
[No Abstract] [Full Text] [Related]
11. Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis.
Meyer HJ; Gundermann P; Surov A
Medicine (Baltimore); 2019 Oct; 98(40):e17472. PubMed ID: 31577779
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Metabolic Tumor Volume
Lee SH; Hwang HK; Lee WJ; Yun M; Kang CM
Gut Liver; 2019 May; 13(3):356-365. PubMed ID: 30602217
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.
Zhang Y; Qin L; Zhang C
Med Sci Monit; 2017 Oct; 23():4947-4953. PubMed ID: 29036034
[TBL] [Abstract][Full Text] [Related]
14. Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
Chong JU; Hwang HK; Lee JH; Yun M; Kang CM; Lee WJ
PLoS One; 2017; 12(2):e0172606. PubMed ID: 28235029
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.
Wegner CS; Gaustad JV; Andersen LM; Simonsen TG; Rofstad EK
J Transl Med; 2016 Jun; 14(1):161. PubMed ID: 27268062
[TBL] [Abstract][Full Text] [Related]
16. PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.
Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Wu CH; Chen XJ; Kuo TC; Yang SH; Shih IL; Lai HS; Shih TT
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1753-64. PubMed ID: 26993317
[TBL] [Abstract][Full Text] [Related]
17. Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.
Xu YP; Yang M
World J Gastrointest Oncol; 2016 Feb; 8(2):165-72. PubMed ID: 26909131
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 18F-fluorodeoxyglucose positron emission tomography and pathologic differentiation in pancreatic cancer.
Ahn SJ; Park MS; Lee JD; Kang WJ
Ann Nucl Med; 2014 Jun; 28(5):430-5. PubMed ID: 24623151
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
